The alveolar macrophages isolated from patients with HP have elevated levels of the co-stimulatory molecules CD80 and CD86[24], while blockade of the CD80/86–CD28 co-stimulation pathway confers protection from experimental HP[25]. This evidence concerns the gene CD86 and hypersensitivity pneumonitis.